Regulatory Perspective of the CMC Considerations for Nanodrug Development

Regulatory Perspective of the CMC Considerations for Nanodrug Development

WANG Guanyu, JIA Audrey, YUAN Dan, WANG Yunhong, WANG Yong*

PDF(6922 KB)

主办：上海医药工业研究院
　　　中国药学会
　　　中国化学制药工业协会
ISSN 1001-8255 CN 31-1243/R ZYGZEA

PDF(6922 KB)

Chinese Journal of Pharmaceuticals ›› 2019, Vol. 50 ›› Issue (10) : 1215-1227. DOI: 10.16522/j.cnki.cjph.2019.10.015

Policy & Regulation

Regulatory Perspective of the CMC Considerations for Nanodrug Development

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2019, 50(10): 1215-1227 https://doi.org/10.16522/j.cnki.cjph.2019.10.015

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(6922 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉